Atlas Trials

Multi-omics Based Prediction of Treatment Response to Immunotherapy Combined with Chemotherapy in Advanced Gastric/Gastroesophageal Junction Cancer.

Clinical trial NCT06642857 · RECRUITING

Trial details

NCT number
NCT06642857
Sponsor
Xiangdong Cheng
Status
RECRUITING
Study type
OBSERVATIONAL
Advanced Gastric CarcinomaAdvanced Gastroesophageal Junction Adenocarcinoma
Start date
2024-03-25
Primary completion
2026-02-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.